Wide Ranks

BIAFW

bioAffinity Technologies, Inc.

0.7464

Top Statistics
Market Cap 0.0000 Forward PE 0.0000 Revenue Growth 12047.40 %
Current Ratio 1.15 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -119.41 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins -119.41 % Operating Margins -87.08 %
Balance Sheet
Total Cash 801311 Total Cash Per Share 0.0600 Total Debt 1 M
Total Debt To Equity 40.20 Current Ratio 1.15 Book Value Per Share 0.5170
All Measures
Message Board Id finmb_423045573 Return On Equity -1.52 City San Antonio
Uuid 161da299-1f9e-36c5-92e1-35f41187c175 Previous Close 0.6000 Book Value 0.5170
Beta 3.12 Total Debt 1 M Volume 1000
Price To Book 1.44 Fifty Two Week Low 0.6100 Total Cash Per Share 0.0600
Total Revenue 7 M Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -87.08 % Net Income To Common -8736142 Trailing Peg Ratio None
Total Cash 801311 Revenue Per Share 0.7440 Ebitda Margins -109.82 %
Trailing PE 0.0000 Regular Market Previous Close 0.6000 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Open 0.6100 Free Cashflow -4287389
State TX Dividend Yield 0.00 % Return On Assets -0.6978
Time Zone Short Name EST Day Low 0.6100 Address1 22211 West Interstate 10
Target High Price 0.0000 Price Hint 4 Website https://www.bioaffinitytech.com
Forward Eps 0.0000 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 103.00 % Is_sp_500 False Regular Market Day High 0.7464
Profit Margins -119.41 % Debt To Equity 40.20 Fifty Two Week High 0.7464
Day High 0.7464 Regular Market Open 0.6100 Industry Key diagnostics-research
Earnings Growth 0.00 % Revenue Growth 12047.40 % Operating Cashflow -7027216
Currency USD Time Zone Full Name America/New_York Is_nasdaq_100 False
Market Cap 0.0000 Zip 78257 Quote Type EQUITY
Industry Diagnostics & Research Long Name bioAffinity Technologies, Inc. Regular Market Day Low 0.6100
Current Price 0.7464 Address2 Suite 1206 Financial Currency USD
Current Ratio 1.15 Gross Margins 35.47 % Industry Disp Diagnostics & Research
Country United States Float Shares 8 M Forward PE 0.0000
Regular Market Volume 1000 Ebitda -8034549 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung.

It offers CyPath lung, a diagnostic test, for early detection of lung cancer.

The company was incorporated in 2014 and is based in San Antonio, Texas.